1. The role of GPLD1 in chronic diseases
   Jing Cao et al, 2023, Journal of Cellular Physiology CrossRef
2. AuNPs/CNC Nanocomposite with A “Dual Dispersion” Effect for LDI‐TOF MS Analysis of Intact Proteins in NSCLC Serum Exosomes
   Liang Shan et al, 2024, Advanced Science CrossRef
3. Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator
   Mostafa Hamada et al, 2024, Biomedicines CrossRef
4. Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment
   Brenda C O'Connell et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef
5. Cancer Stem Cell Metastatic Checkpoints and Glycosylation Patterns: Implications for Therapeutic Strategies
   Sara Sadat Aghamiri et al, 2024, Kinases and Phosphatases CrossRef